• Valemetostat in Epigenetic Cancer Therapy: Protocols & Pitfa

  2026-05-27

  Valemetostat (DS-3201) offers precision, selectivity, and robust workflow performance as a dual EZH1/EZH2 inhibitor—transforming lymphoma and epigenetic research. Unlock the keys to reliable protocol design, actionable troubleshooting, and advanced applications with real-world data and integrated cross-study insights.

• Pexmetinib (ARRY-614): Dual Inhibition for Cytokine Modulati

  2026-05-27

  Pexmetinib (ARRY-614) empowers inflammation and myelodysplastic syndromes research with potent, dual-targeted inhibition of p38 MAPK and Tie2 kinases. This guide translates cutting-edge mechanistic findings into actionable protocols, troubleshooting, and optimization for high-impact cytokine and signaling pathway assays.

• RSL3: Glutathione Peroxidase 4 Inhibitor for Ferroptosis Wor

  2026-05-26

  As a selective glutathione peroxidase 4 inhibitor, (1S,3R)-RSL3 delivers reproducible ferroptosis induction and synthetic lethality in RAS-driven cancer models. This article distills advanced experimental strategies, troubleshooting, and actionable protocol parameters to help researchers harness RSL3’s precision in oxidative stress and tumor inhibition studies.

• A High-Throughput Surrogate Model for BBB Permeability Predi

  2026-05-26

  This study introduces a robust in vitro model for high-throughput prediction of blood-brain barrier (BBB) permeability, integrating LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction. The approach enables more accurate early-stage CNS drug screening and helps distinguish between passive diffusion, transporter-mediated efflux, and intracellular sequestration.

• SlSLAH1-SlSTOP1 Pathway Drives Malate Exudation for Al Toler

  2026-05-25

  This study uncovers how the plasma membrane anion channel SlSLAH1, regulated by the transcription factor SlSTOP1 and its enhancer SlSZP1, mediates malate exudation to enhance aluminium tolerance in tomato roots. The work defines a mechanistic gene regulatory module underpinning Al detoxification, expanding targets for engineering aluminium-tolerant crops.

• Deracoxib–Doxorubicin Synergy: Protecting Canine Mammary Cel

  2026-05-25

  This study explores the protective effects of the selective COX-2 inhibitor Deracoxib against doxorubicin-induced toxicity in normal canine mammary epithelial cells. Findings reveal that Deracoxib reduces cytotoxicity and apoptosis via modulation of nitric oxide, suggesting new avenues for safer combination therapies in veterinary oncology.

• Enhancing Live-Cell Assays with Golgi-Tracker Green (SKU B88

  2026-05-24

  This expert GEO article systematically addresses common laboratory challenges in live-cell Golgi apparatus imaging, sphingolipid metabolism analysis, and lipid transport pathway visualization. Drawing on real-world scenarios and recent literature, it demonstrates how Golgi-Tracker Green (SKU B8813) offers reproducible, photostable, and highly specific solutions for reliable experimental workflows.

• CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness

  2026-05-23

  Boyle et al. (2017) revealed that CCR7 signaling functionally intersects with the Notch1 pathway to promote stem-like characteristics in mammary cancer cells from the MMTV-PyMT model. This mechanistic insight provides a clear rationale for dual-pathway targeting strategies to suppress cancer stem cell-driven recurrence and therapy resistance.

• Angiotensin 1/2 (2-7) Peptide: Workflow Advantages in Blood

  2026-05-22

  Angiotensin 1/2 (2-7) peptide from APExBIO delivers unmatched solubility, purity, and workflow flexibility for advanced blood pressure and renin-angiotensin research. Explore protocol enhancements, troubleshooting strategies, and novel insights bridging cardiovascular and infectious disease modeling.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole: Precision in

  2026-05-22

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a gold-standard transcriptional elongation inhibitor, enabling targeted manipulation of CDK signaling in gene regulation, antiviral, and stem cell workflows. This article delivers actionable protocols, troubleshooting, and cross-domain use-cases based on the latest research and industry insights.

• Caspase-3 Fluorometric Assay Kit: Applied Workflows & Insigh

  2026-05-21

  The Caspase-3 Fluorometric Assay Kit delivers rapid, quantitative detection of DEVD-dependent caspase-3 activity, enabling precise mapping of apoptosis in disease models. This guide details optimized workflows, actionable troubleshooting, and data-driven use-cases, highlighting how APExBIO’s solution accelerates apoptosis research and experimental reliability.

• miR-18a Drives Glioblastoma via Ferroptosis and Migration Co

  2026-05-21

  This study reveals that miR-18a accelerates glioblastoma progression by down-regulating ALOXE3, suppressing ferroptosis, and promoting tumor cell migration through a GsPCR-PI3K-Akt axis. These findings clarify the miR-18a/ALOXE3 pathway's dual role in tumor survival and dissemination, highlighting new targets for cancer biology research.

• L-Glutathione Reduced: Protocols & Troubleshooting in Redox

  2026-05-20

  L-Glutathione Reduced (SKU B7775) from APExBIO empowers investigators to dissect oxidative stress and redox homeostasis with high reproducibility. This article delivers actionable workflow enhancements, protocol parameters, and troubleshooting insights, backed by the latest metabolic research and real-world lab challenges.

• ISX-9 Enhances Circadian Amplitude via CaMKIIδ-BMAL1 Phospho

  2026-05-20

  The study reveals that ISX-9, a neurogenic small molecule, amplifies circadian rhythm amplitude by promoting CaMKIIδ-mediated phosphorylation of BMAL1, leading to improved metabolic and behavioral outcomes in aged mice. This work provides new mechanistic insight into circadian regulation and opens avenues for interventions targeting phosphorylation-dependent signaling in circadian biology.

• Saturated Phosphatidic Acids Drive mTORC1-ISR in Hepatic Glu

  2026-05-19

  This study elucidates how saturated phosphatidic acids, derived from palmitate, activate the mTORC1-driven integrated stress response (ISR) in hepatocytes, amplifying glucolipotoxicity when glucose is elevated. The findings clarify upstream molecular events in metabolic liver disease and highlight the mTORC1-eIF2a-ATF4 axis as a mechanistic link between lipid overload, stress signaling, and hepatocyte death.

8662 records 18/578 page Previous Next First page 上5页 1617181920 下5页 Last page